1 |
Laderach DJ, Compagno D. Inhibition of galectins in cancer: Biological challenges for their clinical application. Front Immunol 2022;13:1104625. [PMID: 36703969 DOI: 10.3389/fimmu.2022.1104625] [Reference Citation Analysis]
|
2 |
van Klaveren S, Dernovšek J, Jakopin Ž, Anderluh M, Leffler H, Nilsson UJ, Tomašič T. Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1, -3 and -8 inhibitors. RSC Adv 2022;12:18973-84. [PMID: 35873334 DOI: 10.1039/d2ra03163a] [Reference Citation Analysis]
|
3 |
van Klaveren S, Sundin AP, Jakopin Ž, Anderluh M, Leffler H, Nilsson UJ, Tomašič T. Selective Galectin-8N Ligands: The Design and Synthesis of Phthalazinone-d-Galactals. ChemMedChem 2021;:e202100575. [PMID: 34913595 DOI: 10.1002/cmdc.202100575] [Reference Citation Analysis]
|
4 |
Li W, Sancho A, Chung WL, Vinik Y, Groll J, Zick Y, Medalia O, Bershadsky AD, Geiger B. Differential cellular responses to adhesive interactions with galectin-8- and fibronectin-coated substrates. J Cell Sci 2021;134:jcs252221. [PMID: 33722978 DOI: 10.1242/jcs.252221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
5 |
Gómez-Redondo M, Delgado S, Núñez-Franco R, Jiménez-Osés G, Ardá A, Jiménez-Barbero J, Gimeno A. The two domains of human galectin-8 bind sialyl- and fucose-containing oligosaccharides in an independent manner. A 3D view by using NMR. RSC Chem Biol 2021;2:932-41. [PMID: 34179785 DOI: 10.1039/d1cb00051a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|